Respiratory outcomes of “new” bronchopulmonary dysplasia in adolescents: A multicenter study
Santiago Pérez‐Tarazona, Santiago Rueda Esteban, María Luz García‐García, Maria Arroyas Sanchez, Inés de Mir Messa, Tatiana Acevedo Valarezo, Orlando Mesa Medina, Alicia Callejón Callejón, Elisa María Canino Calderín, Salome Albi Rodriguez, Roser Ayats, Antonio Salcedo Posadas, J. Colomer, X. Domingo Miró, Montserrat Berrocal Castañeda, Ana Villares Porto‐Dominguez, the Working Group of Perinatal Respiratory Diseases of the Spanish Society of Pediatric Pulmonology
Abstract
OBJECTIVE: Long-term respiratory consequences of bronchopulmonary dysplasia (BPD) in preterm infants born in the post-surfactant era ("new" BPD) remain partially unknown. The present study aimed to evaluate the respiratory outcomes of "new" BPD in adolescents who were born preterm. METHODS: This multicenter, cross-sectional study included 286 adolescents born between 2003 and 2005 (mean age: 14.2 years); among them, 184 and 102 were born extremely preterm (EP; <28 weeks' gestation) and moderate-late preterm (32 to <37 weeks' gestation), respectively. Among EP adolescents, 92 had BPD, and 92 did not. All participants underwent lung function tests, skin prick testing, and questionnaires on asthma symptoms and quality of life. RESULTS: /FVC ratios were below the lower limit of normal (z-score <-1.645) in 30.4% of EP adolescents with BPD, 13.0% of EP adolescents without BPD, and 11.8% of adolescents who were born moderate-late preterm. Bronchodilator response and air-trapping were significantly higher in BPD adolescents than in other adolescents. Diffusion capacity was significantly lower in EP adolescents than in moderate-late preterm adolescents. Asthma symptoms and quality-of-life scores were similar among groups. CONCLUSION: EP adolescents with "new" BPD had poorer pulmonary function than EP adolescents without BPD or moderate-late preterm adolescents. Further studies are needed to determine whether "new" BPD is associated with early-onset chronic obstructive pulmonary disease in adulthood.